CML treatment – Globalstar International https://export.globalstarco.com Making Health Accessible. Thu, 05 Mar 2026 10:46:28 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://export.globalstarco.com/wp-content/uploads/2025/07/cropped-Site-Icon-32x32.png CML treatment – Globalstar International https://export.globalstarco.com 32 32 L-Asparaginase (10000 IU) https://export.globalstarco.com/product/l-asparaginase-10000-iu/ https://export.globalstarco.com/product/l-asparaginase-10000-iu/#respond Wed, 18 Feb 2026 10:55:09 +0000 https://export.globalstarco.com/product/l-asparaginase-10000-iu/ Overview: Busulfan 2 mg Tablet contains Busulfan (2 mg) and is a prescription oral alkylating anticancer medicine used in the treatment of chronic myelogenous leukemia (CML) and as part of conditioning regimens before bone marrow transplantation by interfering with DNA replication in cancer cells. Key Benefits: – Effective in managing CML and preparative regimens for stem cell transplant – Inhibits DNA synthesis and cancer cell proliferation – Oral dosing for convenient administration Composition: Busulfan (2 mg) How It Works: Busulfan is an alkylating agent that forms cross-links in DNA strands, preventing cancer cell division and leading to cell death, particularly in rapidly dividing hematologic malignancies. Usage Instructions: – Take exactly as directed by your healthcare provider – Swallow the tablet with water, with or without food – Do not crush or chew the tablet Side Effects: – Low blood cell counts increasing infection and bleeding risk – Nausea, vomiting, diarrhea – Headache, fatigue Precautions: – Regular monitoring of blood counts and organ function is required – Avoid use during pregnancy and breastfeeding unless clearly advised by a physician – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

]]>
https://export.globalstarco.com/product/l-asparaginase-10000-iu/feed/ 0
Ibrutinib (140 mg) https://export.globalstarco.com/product/ibrutinib-140-mg/ https://export.globalstarco.com/product/ibrutinib-140-mg/#respond Wed, 18 Feb 2026 10:55:06 +0000 https://export.globalstarco.com/product/ibrutinib-140-mg/ Overview: Hydroxyurea Capsule 500 mg contains Hydroxyurea (500 mg) and is prescribed as an oral antineoplastic and antimetabolite medicine used in the treatment of chronic myeloid leukemia (CML), sickle cell anemia, and certain other cancers by inhibiting DNA synthesis in rapidly dividing cells. Key Benefits: – Helps control leukemic cell proliferation in CML – Reduces painful episodes in sickle cell anemia – Oral dosing for convenient administration Composition: Hydroxyurea (500 mg) How It Works: Hydroxyurea inhibits ribonucleotide reductase, an enzyme essential for DNA synthesis, slowing the replication of rapidly dividing cells including cancer cells and abnormal blood cells. Usage Instructions: – Take exactly as directed by your healthcare provider – Swallow the capsule with water, with or without food – Do not crush or chew the capsule Side Effects: – Low blood cell counts increasing infection and bleeding risk – Nausea, vomiting, diarrhea – Mouth sores, headache Precautions: – Regular monitoring of blood counts and organ function is required – Not recommended during pregnancy or breastfeeding unless clearly advised by a doctor – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

]]>
https://export.globalstarco.com/product/ibrutinib-140-mg/feed/ 0
Methotrexate (2.5 mg) https://export.globalstarco.com/product/methotrexate-2-5-mg/ https://export.globalstarco.com/product/methotrexate-2-5-mg/#respond Wed, 18 Feb 2026 10:55:01 +0000 https://export.globalstarco.com/product/methotrexate-2-5-mg/ Overview: Zydus Imat 400 mg Tablet is a prescription anticancer medicine containing Imatinib Mesylate (400 mg), belonging to the class of tyrosine kinase inhibitors. It is used to treat specific cancers by targeting abnormal proteins involved in cancer cell growth and division. Key Benefits: – Effective in managing chronic myeloid leukaemia (CML) – Helps control progression of gastrointestinal stromal tumors (GIST) – Oral therapy with once-daily dosing – Widely prescribed by oncologists for targeted cancer treatment Composition: Imatinib Mesylate (400 mg) How It Works: Imatinib blocks the activity of BCR-ABL and other tyrosine kinases, which are proteins that promote the growth and spread of cancer cells. This targeted action slows tumor progression and reduces cancer cell proliferation. Usage Instructions: – Take exactly as prescribed by your healthcare provider – Swallow the tablet whole with water, with or without food – Do not chew or crush the tablet Side Effects: – Nausea, vomiting, diarrhea, headache, fatigue – Fluid retention, edema, muscle cramps – Rash, abdominal pain, loss of appetite Precautions: – Not recommended during pregnancy or breastfeeding – use effective contraception during treatment :contentReference[oaicite:0]{index=0} – Inform your doctor about all medications you are taking to avoid interactions – Regular monitoring of blood counts and liver function is advised Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and direct sunlight Manufacturer: Zydus Cadila Life Sciences Ltd Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

]]>
https://export.globalstarco.com/product/methotrexate-2-5-mg/feed/ 0